Key Dates and Disclosure Events Embecta Shareholders Need to Know: From "Incredibly Resolute" Pen Needle Claims to a 57.8% Stock CollapseNEW YORK, Aug. 6, 2026 /PRNewswire/ -- November 25, 2025. January 14, 2026. February 5, 2026. May 5, 2026. Between these dates, Embecta Corp. (NASDAQ:EMBC) shareh…
Important Notice Regarding Alleged Pen Needle Revenue Misrepresentations That Cost Embecta Investors Over 57% of Share ValueNEW YORK, July 30, 2026 /PRNewswire/ -- SueWallSt notifies investors in Embecta Corp. (NASDAQ:EMBC) that a class action lawsuit has been filed on behalf of shareholders who pu…
Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the Embecta Corp. Securities Class Action Where Shareholders Lost $5.35 Per ShareNEW YORK, July 23, 2026 /PRNewswire/ -- IMPORTANT DATE: August 17, 2026. Investors who purchased Embecta Corp. (NASDAQ:EMBC) securities between…
SAN FRANCISCO, July 7, 2026 /PRNewswire/ -- Embecta Corp. (NASDAQ:EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company's disastrous Q2 2026 earnings…
A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin pen needle product category.NEW YORK, July 7, 2026 /PRNewswire/ -- Leading securities law firm Bl…
